Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Oligino

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Gene Therapy|February 12, 1998
Rapid method for construction of recombinant HSV gene transfer vectorsD M Krisky, P C Marconi, T Oligino, et al.
Gene Therapy|October 12, 1999
Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritisT Oligino, S Ghivizzani, D Wolfe, et al.
Gene Therapy|October 1, 1996
In vivo transgene activation from an HSV-based gene therapy vector by GAL4:vp16T Oligino, P L Poliani, P Marconi, et al.
Gene Therapy|June 6, 1998
Drug inducible transgene expression in brain using a herpes simplex virus vectorT Oligino, P L Poliani, Y Wang, et al.
Journal of Neurovirology|May 1, 1997
Herpes simplex virus vectors for gene transfer to the nervous systemW F Goins, D Krisky, P Marconi, et al.
Neuromuscular Disorders : NMD|June 19, 1998
Implications of maturation for viral gene delivery to skeletal muscleJ C van Deutekom, S S Floyd, D K Booth, et al.
Gynecologic Oncology|November 25, 1998
High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type 1 vectorM Wang, C Rancourt, J G Navarro, et al.
Gene Therapy|January 9, 2004
Gene delivery to cartilage defects using coagulated bone marrow aspirateA Pascher, G D Palmer, A Steinert, et al.
Biochemical and Biophysical Research Communications|December 5, 1998
Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancyT Suzuki, A Piche, K Kasono, et al.
Gene Therapy|February 19, 2000
Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus modelJ Gómez-Navarro, J L Contreras, W Arafat, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Gene Therapy|February 12, 1998
Rapid method for construction of recombinant HSV gene transfer vectorsD M Krisky, P C Marconi, T Oligino, et al.
Gene Therapy|October 12, 1999
Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritisT Oligino, S Ghivizzani, D Wolfe, et al.
Gene Therapy|October 1, 1996
In vivo transgene activation from an HSV-based gene therapy vector by GAL4:vp16T Oligino, P L Poliani, P Marconi, et al.
Gene Therapy|June 6, 1998
Drug inducible transgene expression in brain using a herpes simplex virus vectorT Oligino, P L Poliani, Y Wang, et al.
Journal of Neurovirology|May 1, 1997
Herpes simplex virus vectors for gene transfer to the nervous systemW F Goins, D Krisky, P Marconi, et al.
Neuromuscular Disorders : NMD|June 19, 1998
Implications of maturation for viral gene delivery to skeletal muscleJ C van Deutekom, S S Floyd, D K Booth, et al.
Gynecologic Oncology|November 25, 1998
High-efficacy thymidine kinase gene transfer to ovarian cancer cell lines mediated by herpes simplex virus type 1 vectorM Wang, C Rancourt, J G Navarro, et al.
Gene Therapy|January 9, 2004
Gene delivery to cartilage defects using coagulated bone marrow aspirateA Pascher, G D Palmer, A Steinert, et al.
Biochemical and Biophysical Research Communications|December 5, 1998
Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancyT Suzuki, A Piche, K Kasono, et al.
Gene Therapy|February 19, 2000
Genetically modified CD34+ cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus modelJ Gómez-Navarro, J L Contreras, W Arafat, et al.
Pageof 2